Skip to Main Content

Author Details

Manuel Fuentes
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
2002
121
28
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36455696Translational research into frailty from bench to bedside: Salivary biomarkers for inflammaging.Exp Gerontol2023
36986749Improving Properties of Podophyllic Aldehyde-Derived Cyclolignans: Design, Synthesis and Evaluation of Novel Lignohydroquinones, Dual-Selective Hybrids against Colorectal Cancer Cells.Pharmaceutics2023
37370813Enhancement of Tumor Cell Immunogenicity and Antitumor Properties Derived from Platinum-Conjugated Iron Nanoparticles.Cancers (Basel)2023
36475733Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project.J Proteome Res2023
36765855Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution.Cancers (Basel)2023
34758407Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis.J Proteomics2022
35743151Single-Cell Proteomics: The Critical Role of Nanotechnology.Int J Mol Sci2022
35858906Comprehensive and systematic characterization of multi-functionalized cisplatin nano-conjugate: from the chemistry and proteomic biocompatibility to the animal model.J Nanobiotechnology2022
36248816Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction.Front Immunol2022
36168869Systematic evaluation of plasma signaling cascades by functional proteomics approaches: SARS-CoV-2 infection as model.Proteomics Clin Appl2022
35053611Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid.Cancers (Basel)2022
34115349Systematic and Rational Design of Protein Arrays in Noncontact Printers: Pipeline and Critical Aspects.Methods Mol Biol2021
33859640Dynamic Intracellular Metabolic Cell Signaling Profiles During Ag-Dependent B-Cell Differentiation.Front Immunol2021
35008477A Quantitative Systems Approach to Define Novel Effects of Tumour p53 Mutations on Binding Oncoprotein MDM2.Int J Mol Sci2021
34944421Deepening into Intracellular Signaling Landscape through Integrative Spatial Proteomics and Transcriptomics in a Lymphoma Model.Biomolecules2021
34072782Tracking the Antibody Immunome in Sporadic Colorectal Cancer by Using Antigen Self-Assembled Protein Arrays.Cancers (Basel)2021
34123866Deciphering Human Leukocyte Antigen Susceptibility Maps From Immunopeptidomics Characterization in Oncology and Infections.Front Cell Infect Microbiol2021
34360795Autoimmune Responses in Oncology: Causes and Significance.Int J Mol Sci2021
34198850Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies.Cancers (Basel)2021
34115362Deciphering Intracellular Signaling Pathways in Tumoral Pathologies.Methods Mol Biol2021
32455562Detection of Human p53 In-Vitro Expressed in a Transcription-Translation Cell-Free System by a Novel Conjugate Based on Cadmium Sulphide Nanoparticles.Nanomaterials (Basel)2020
31939123Stabilization of Multimeric Enzymes via Immobilization and Further Cross-Linking with Aldehyde-Dextran.Methods Mol Biol2020
31939120Very Strong but Reversible Immobilization of Enzymes on Supports Coated with Ionic Polymers.Methods Mol Biol2020
32957517A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor.Molecules2020
32610601Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers.Nanomaterials (Basel)2020
32514411Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over <i>In Vitro</i> Retinal Photoreceptor Degeneration.Mol Ther Methods Clin Dev2020
30276735A Systematic Analysis Workflow for High-Density Customized Protein Microarrays in Biomarker Screening.Methods Mol Biol2019
31471297Discovery of an autoantibody signature for the early diagnosis of knee osteoarthritis: data from the Osteoarthritis Initiative.Ann Rheum Dis2019
31554176Interactions of Nanoparticles and Biosystems: Microenvironment of Nanoparticles and Biomolecules in Nanomedicine.Nanomaterials (Basel)2019
31136180Identification of Alzheimer's Disease Autoantibodies and Their Target Biomarkers by Phage Microarrays.J Proteome Res2019
30553075A decade of Nucleic Acid Programmable Protein Arrays (NAPPA) availability: News, actors, progress, prospects and access.J Proteomics2019
30594577Exosome beads array for multiplexed phenotyping in cancer.J Proteomics2019
29116516Screening Phage-Display Antibody Libraries Using Protein Arrays.Methods Mol Biol2018
30016987Self-assembling functional programmable protein array for studying protein-protein interactions in malaria parasites.Malar J2018
29670695New Hybrids Derived from Podophyllic Aldehyde and Diterpenylhydroquinones with Selectivity toward Osteosarcoma Cells.ACS Med Chem Lett2018
29401756In-Depth Proteomic Characterization of Classical and Non-Classical Monocyte Subsets.Proteomes2018
29282898A Perspective on Proteomics of Infectious Diseases.Proteomics Clin Appl2018
28004597Functional proteomic insights in B-cell chronic lymphocytic leukemia.Expert Rev Proteomics2017
28379711Screening and Validation of Novel Biomarkers in Osteoarticular Pathologies by Comprehensive Combination of Protein Array Technologies.J Proteome Res2017
28353226Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.Adv Exp Med Biol2017
28293970CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.Expert Rev Proteomics2017
28467808A systematic approach for peptide characterization of B-cell receptor in chronic lymphocytic leukemia cells.Oncotarget2017
28581009Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells.Metallomics2017
28681874Functional insights into the cellular response triggered by a bile-acid platinum compound conjugated to biocompatible ferric nanoparticles using quantitative proteomic approaches.Nanoscale2017
27989941A multicentric study to evaluate the use of relative retention times in targeted proteomics.J Proteomics2017
28040889Comprehensive and Systematic Analysis of the Immunocompatibility of Polyelectrolyte Capsules.Bioconjug Chem2017
26910488Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia.Proteomics2016
26614077Nanotechnology in the Fabrication of Protein Microarrays.Methods Mol Biol2016
28003549First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases.Sci Transl Med2016
27686811Proteogenomics for the Comprehensive Analysis of Human Cellular and Serum Antibody Repertoires.Adv Exp Med Biol2016
  • 1 - 50 of 121

Recommended Authors

Columbia University
Career Start Year 2015
Number of shared co-authors 6
KTH - Royal Institute of Technology
Career Start Year 2011
Number of shared co-authors 6
The Royal Institute of Technology (KTH)
Career Start Year 2011
Number of shared co-authors 6
AlbaNova University Center, KTH Royal Institute of Technology
Career Start Year 2008
Number of shared co-authors 5
Mount Sinai Hospital
Career Start Year 2007
Number of shared co-authors 0
Functional Genomics Center Zurich (FGCZ)-University of Zurich/ETH Zurich
Career Start Year 2007
Number of shared co-authors 0
Genentech Inc.
Career Start Year 2006
Number of shared co-authors 3
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 5
Uppsala University
Career Start Year 2005
Number of shared co-authors 5
Nuclea Biotechnologies
Career Start Year 2005
Number of shared co-authors 4
Institute for Bioanalysis, Coburg University of Applied Sciences and Arts
Career Start Year 2004
Number of shared co-authors 0
University of Basel
Career Start Year 2004
Number of shared co-authors 2
Universitatsklinikum
Career Start Year 2002
Number of shared co-authors 1
Stanford University
Career Start Year 2000
Number of shared co-authors 6
Harvard Partners Center For Genetics and Genomics
Career Start Year 1998
Number of shared co-authors 4
ETH Zurich
Career Start Year 1998
Number of shared co-authors 5
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1998
Number of shared co-authors 4
Eastern Virginia Medical School
Career Start Year 1997
Number of shared co-authors 2
Universite PSL, LPC CNRS UMR8249
Career Start Year 1997
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 7
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 2
University of Virginia
Career Start Year 1994
Number of shared co-authors 0
Utrecht University
Career Start Year 1991
Number of shared co-authors 8
Institute of Microbiology of the CAS
Career Start Year 1991
Number of shared co-authors 6
Lund University Cancer Centre
Career Start Year 1989
Number of shared co-authors 2
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 1988
Number of shared co-authors 10
University of Cape Town
Career Start Year 1988
Number of shared co-authors 1
Institute for Systems Biology
Career Start Year 1985
Number of shared co-authors 26
Lund University
Career Start Year 1977
Number of shared co-authors 4
University of Texas MD Anderson Cancer Center
Career Start Year 1977
Number of shared co-authors 18

Collaborators

Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Co-authored papers 34
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Co-authored papers 27
Cancer Research Center (CSIC/USAL/IBSAL)
Co-authored papers 13
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Co-authored papers 12
Biodesign Institute, Arizona State University
Co-authored papers 11
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Co-authored papers 9
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Co-authored papers 9
National Center for Biotechnology
Co-authored papers 8
Lund University
Co-authored papers 7
Karolinska Institutet
Co-authored papers 7
Biomedical Center, Lund University
Co-authored papers 7
Center for Applied Medical Research (CIMA)
Co-authored papers 6
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Co-authored papers 6
KTH Royal Institute of Technology
Co-authored papers 5
Max-Planck-Institut fur Entwicklungsbiologie
Co-authored papers 5
Groningen Research Institute of Pharmacy, University of Groningen
Co-authored papers 4
Falk Center for Molecular Therapeutics, Northwestern University
Co-authored papers 3
National Center for Biotechnology
Co-authored papers 3
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers 3
Northeastern University
Co-authored papers 2
NYU Grossman School of Medicine
Co-authored papers 2
Virginia Commonwealth University
Co-authored papers 2
Linkoping University
Co-authored papers 2
Groningen Research Institute of Pharmacy, University of Groningen
Co-authored papers 2
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
Washington University School of Medicine
Co-authored papers 2
Indian Institute of Technology Bombay
Co-authored papers 2
Co-authored papers 2
College of Life Sciences and Biotechnology, Yonsei University
Co-authored papers 2
Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED)
Co-authored papers 2